Philippe Mabo Selected Research

hydroquinidine (dihydroquinidine)

1/2017	The QUIDAM study: Hydroquinidine therapy for the management of Brugada syndrome patients at high arrhythmic risk.
4/2007	Clinical aspects and prognosis of Brugada syndrome in children.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philippe Mabo Research Topics

Disease

28	Heart Failure 01/2022 - 01/2002
15	Brugada Syndrome 05/2022 - 11/2006
13	Atrial Fibrillation 01/2019 - 01/2003
8	Cardiac Arrhythmias (Arrythmia) 01/2021 - 02/2012
8	Cardiac Sudden Death (Sudden Cardiac Arrest) 03/2020 - 04/2007
8	Shock 03/2020 - 04/2007
6	Ventricular Tachycardia 05/2019 - 07/2003
5	Infections 09/2020 - 10/2003
5	Sudden Death 01/2018 - 12/2005
3	Syncope (Fainting) 01/2022 - 10/2013
3	Stroke (Strokes) 01/2019 - 06/2017
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2018 - 06/2013
3	Ventricular Fibrillation 01/2017 - 05/2008
3	Bundle-Branch Block (Fascicular Block) 12/2016 - 10/2009
3	Left Ventricular Dysfunction 03/2013 - 02/2007
3	Atrioventricular Block 09/2012 - 01/2005
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Heart Arrest (Cardiac Arrest) 01/2018 - 12/2017
2	Cardiomyopathies (Cardiomyopathy) 01/2016 - 03/2013
2	Heart Diseases (Heart Disease) 04/2012 - 03/2012
2	Myocardial Infarction 04/2012 - 11/2010
2	Tachycardia (Tachyarrhythmias) 12/2008 - 04/2002
1	Endocarditis 10/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 10/2021
1	Essential Thrombocythemia 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Cicatrix (Scar) 01/2020
1	Fever (Fevers) 01/2019
1	Laminopathies 01/2019
1	Diabetes Mellitus 01/2018
1	Frailty 01/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2018
1	Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy) 01/2018
1	Left Ventricular Outflow Obstruction 01/2018
1	Embolism (Embolus) 07/2017
1	Wounds and Injuries (Trauma) 06/2017
1	Drug Resistant Epilepsy 01/2017
1	Multiple Organ Failure (MODS) 01/2017
1	Cardiogenic Shock 01/2017
1	Mitral Valve Stenosis (Mitral Stenosis) 01/2016
1	Hemorrhage 01/2016
1	Ventricular Remodeling 06/2014
1	Thrombosis (Thrombus) 03/2014
1	Atrial Remodeling 11/2012
1	Congenital Heart Defects (Congenital Heart Defect) 09/2012
1	Polymorphic catecholergic ventricular tachycardia 06/2012
1	Liver Diseases (Liver Disease) 10/2009
1	Familial Sudden Death 10/2009
1	Atrial Flutter (Flutter, Atrial) 06/2009
1	Channelopathies 03/2009

Drug/Important Bio-Agent (IBA)

5	Anti-Arrhythmia AgentsIBA 01/2019 - 02/2013
5	Pharmaceutical PreparationsIBA 10/2017 - 01/2002
2	Sodium Channels (Sodium Channel)IBA 05/2022 - 01/2022
2	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 06/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 09/2020 - 10/2003
2	Quinidine (Chinidin)FDA LinkGeneric 01/2019 - 12/2009
2	Dihydrotachysterol (AT 10)IBA 01/2018 - 10/2013
2	Sodium Channel BlockersIBA 10/2017 - 10/2017
2	hydroquinidine (dihydroquinidine)IBA 01/2017 - 04/2007
2	Vitamin K FDA Link 01/2016 - 07/2013
2	Ajmaline (Wolfina)FDA Link 06/2014 - 10/2009
2	AntibodiesIBA 09/2012 - 03/2012
1	Indicators and Reagents (Reagents)IBA 01/2022
1	N 30IBA 10/2019
1	P-2 (P 2)IBA 01/2019
1	AntralIBA 05/2018
1	Hemoglobins (Hemoglobin)IBA 01/2018
1	PotassiumIBA 01/2018
1	apixabanIBA 07/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2017
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2017
1	Factor Xa InhibitorsIBA 01/2016
1	Factor IIaIBA 01/2016
1	GadoliniumIBA 01/2016
1	AnticoagulantsIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	CalsequestrinIBA 06/2012
1	CalciumIBA 06/2012
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 06/2012
1	triadinIBA 06/2012
1	Flecainide (Tambocor)FDA LinkGeneric 04/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2010

Therapy/Procedure

26	Cardiac Resynchronization Therapy 10/2021 - 01/2003
24	Therapeutics 01/2021 - 07/2003
21	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2022 - 07/2003
13	Defibrillators (Defibrillator) 03/2020 - 10/2003
4	Radiofrequency Ablation 05/2019 - 06/2009
2	Heart Transplantation (Grafting, Heart) 01/2018 - 01/2017
2	Catheter Ablation 01/2018 - 04/2002
2	Vagus Nerve Stimulation 01/2017 - 01/2014
2	Drug Therapy (Chemotherapy) 01/2003 - 01/2002
1	Replantation 10/2021
1	Secondary Prevention 09/2020
1	Device Removal (Removal, Device) 09/2020
1	Renal Dialysis (Hemodialysis) 01/2018
1	Cardiac Rehabilitation 08/2017
1	Extracorporeal Membrane Oxygenation 01/2017
1	Contraindications 01/2016
1	Liver Transplantation 10/2009
1	Transplantation 10/2009